• 
  Claire Bouthier de La Tour, Martine Mathieu, Laura Meyer, Pauline Dupaigne, Fanny Passot, et al.. In vivo and in vitro characterization of DdrC, a DNA damage response protein in Deinococcus radiodurans bacterium. PLoS ONE, 2017, 12 (5), pp.e0177751. ⟨10.1371/journal.pone.0177751⟩. ⟨hal-02187767⟩
• 
  Ewa Blaszczak, Emeline Pasquier, Gaëlle Le Dez, Adrian Odrzywolski, Natalia Lazarewicz, et al.. Dissecting ubiquitylation and DNA damage response pathways in the yeast Saccharomyces cerevisiae using a proteome-wide approach. Molecular and Cellular Proteomics, 2024, Molecular and Cellular Proteomics, 23 (1), pp.100695. ⟨10.1016/j.mcpro.2023.100695⟩. ⟨hal-04355212⟩
• 
  Thomas Kaley, Mehdi Touat, Vivek Subbiah, Antoine Hollebecque, Jordi Rodon, et al.. BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study. Journal of Clinical Oncology, 2018, 36 (35), pp.3477-3484. ⟨10.1200/JCO.2018.78.9990⟩. ⟨hal-04541090⟩
• 
  Prashanth Ashok Kumar, Maryam Karimi, Alina Basnet, Lesley K. Seymour, Robert Arthur Kratzke, et al.. Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data. Clinical Lung Cancer, 2023, 24 (6), pp.528-540. ⟨10.1016/j.cllc.2023.06.002⟩. ⟨hal-04229530⟩
• 
  Laurence Brugières, Nathalie Cozic, Roch Houot, Charlotte Rigaud, David Sibon, et al.. Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcS-crizotinib trial. European Journal of Cancer, 2023, 191, pp.112984. ⟨10.1016/j.ejca.2023.112984⟩. ⟨hal-04228222⟩
• 
  Alice Boilève, Matthieu Faron, Sarah Fodil-Cherif, Arnauld Bayle, Livia Lamartina, et al.. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data. European Journal of Cancer, 2023, 186, pp.122-132. ⟨10.1016/j.ejca.2023.03.024⟩. ⟨hal-04106320⟩
• 
  Pauline Rimmelé, Michela Esposito, Laure Delestré, Jean-Hugues Guervilly, Maya Ridinger-Saison, et al.. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia. Oncotarget, 2017, 8 (23), ⟨10.18632/oncotarget.16183⟩. ⟨hal-02424493⟩
• 
  Anna Gueiderikh, Filippo L Rosselli, Januario B.C. Neto. A never-ending story: the steadily growing family of the FA and FA-like genes. Genetics and Molecular Biology, 2017, 40 (2), pp.398-407. ⟨10.1590/1678-4685-GMB-2016-0213⟩. ⟨hal-02424489⟩
• 
  Thuy Vy Nguyen, Patrycja Pawlikowska, Virginie Firlej, Filippo L Rosselli, Saïd Aoufouchi. V(D)J recombination process and the Pre-B to immature B-cells transition are altered in Fanca−/− mice. Scientific Reports, 2016, 6 (1), pp.36906. ⟨10.1038/srep36906⟩. ⟨hal-02424495⟩
• 
  Anne Helbling-Leclerc, Françoise Dessarps-Freichey, Caroline Evrard, Filippo L Rosselli. Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program. Scientific Reports, 2019, 9 (1), pp.17024. ⟨10.1038/s41598-019-53502-w⟩. ⟨hal-02391873⟩
• 
  Khalda Amr, Patrycja Pawlikowska, Said Aoufouchi, Filippo L Rosselli, Ghada El‐kamah. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine‐responsive megaloblastic anemia in an Egyptian family. Molecular Genetics & Genomic Medicine, 2019, 7 (7), pp.e777. ⟨10.1002/mgg3.777⟩. ⟨hal-02391876⟩
• 
  Anna Gueiderikh, Thomas Sarrade, Youlia M. Kirova, Brigitte de la Lande, Florent de Vathaire, et al.. Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors. Frontiers in Oncology, 2023, 13, ⟨10.3389/fonc.2023.1199043⟩. ⟨hal-04195134⟩
• 
  Sihem Tarfi, Véronique Harrivel, Florent Dumezy, Julien Guy, Mikael Roussel, et al.. Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis. Blood Cancer Journal, 2018, 8 (11), pp.114. ⟨10.1038/s41408-018-0146-8⟩. ⟨hal-04438675⟩
• 
  Awatef Allouch, Laurent Voisin, Yanyan Zhang, Syed Qasim Raza, Yann Lecluse, et al.. CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia. Nature Communications, 2022, 13 (1), pp.6739. ⟨10.1038/s41467-022-34548-3⟩. ⟨hal-04438501⟩
• 
  Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, Pierre Thirion, Matthew Nankivell, et al.. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. Journal of Clinical Oncology, 2023, 41 (28), pp.4535-4547. ⟨10.1200/JCO.22.02279⟩. ⟨hal-04250829⟩
• 
  Renaud Descourt, Maurice Perol, Gaëlle Rousseau-Bussac, David Planchard, Bertrand Mennecier, et al.. Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study). Lung Cancer, 2019, 136, pp.109-114. ⟨10.1016/j.lungcan.2019.08.010⟩. ⟨hal-04529929⟩
• 
  Florent Milliet, Alexandre Bozec, Renaud Schiappa, Julien Viotti, Anouchka Modesto, et al.. Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study. Oral Oncology, 2021, 112, pp.105041. ⟨10.1016/j.oraloncology.2020.105041⟩. ⟨hal-03617423⟩
• 
  Zeinaf Muradova, Désirée Tannous, Ali Mostefa-Kara, Thanh Trang Cao-Pham, Constance Lamy, et al.. Gadolinium-based nanoparticles AGuIX and their combination with ionizing radiation trigger AMPK-dependent proinflammatory reprogramming of tumor-associated macrophages. 2024. ⟨inserm-04529254⟩
• 
  V. Gopalakrishnan, C. N. Spencer, L. Nezi, A. Reuben, M. C. Andrews, et al.. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science, 2018, 359 (6371), pp.97-103. ⟨10.1126/science.aan4236⟩. ⟨hal-02629159⟩
• 
  Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas, Valerio Iebba, Gerard Zalcman, et al.. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nature Medicine, 2022, 28 (2), pp.315-324. ⟨10.1038/s41591-021-01655-5⟩. ⟨hal-03978008⟩

2 178